These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2323670)

  • 1. Bone marrow transplantation with a fixed low number of T-cells in the graft.
    Verdonck LF; de Gast GC; van Heugten HG; Dekker AW
    Haematol Blood Transfus; 1990; 33():707-8. PubMed ID: 2323670
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation in Basel: single center experience from 1973 to 1989.
    Speck B; Nissen C; Tichelli A; Roth J; Dazzi H; Stebler CH; Wernli M; Signer E; Gratwohl A
    Clin Transpl; 1989; ():115-22. PubMed ID: 2487556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of soluble interleukin-2 receptors after bone marrow transplantation.
    Siegert W; Josimovic-Alasevic O; Schwerdtfeger R; Schmidt C; Neubauer A; Henze G; Huhn D; Diamantstein T
    Haematol Blood Transfus; 1990; 33():76-7. PubMed ID: 2323675
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
    de Witte T; Preijers F; Schattenberg A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
    [No Abstract]   [Full Text] [Related]  

  • 6. Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.
    Verdonck LF; Dekker AW; van Heugten H; van Kempen ML; Punt K; de Gast GC
    Haematol Blood Transfus; 1987; 30():563-6. PubMed ID: 3305219
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human bone marrow transplantation.
    Storb R; Buckner CD
    Eur J Clin Invest; 1990 Apr; 20(2):119-32. PubMed ID: 2112475
    [No Abstract]   [Full Text] [Related]  

  • 9. Regeneration of lymphocyte subpopulations after bone marrow transplantation: a study with monoclonal antibodies of the BL-series.
    Pönisch W; Leiblein S; Friedrich T; Schwenke H; Helbig W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):527-30. PubMed ID: 2480302
    [No Abstract]   [Full Text] [Related]  

  • 10. Herpes virus immunity and acute graft-versus-host disease.
    Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bortin MM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2655-7. PubMed ID: 3274576
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
    Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation in pediatrics.
    Abramowsky CR; Coccia PF
    Perspect Pediatr Pathol; 1989; 13():6-43. PubMed ID: 2697854
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
    Storb R; Appelbaum F; Buckner CD; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():80-4. PubMed ID: 2117976
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
    Champlin RE
    Cancer Treat Res; 1990; 50():99-111. PubMed ID: 1976361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft versus host disease prophylaxis today.
    Martelli MF; Aversa F
    Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
    Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell depletion of donor marrow for prevention of acute graft-versus-host disease.
    Martin PJ; Hansen JA; Storb R; Thomas ED
    Haematol Blood Transfus; 1985; 29():42-3. PubMed ID: 3896973
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
    Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R
    N Engl J Med; 1989 Sep; 321(12):784-9. PubMed ID: 2671734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of T-cell depletion for bone marrow transplantation.
    Blaise D; Gravis G; Maraninchi D
    Lancet; 1993 Jan; 341(8836):51-2. PubMed ID: 8093295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.